Alberto Santagostino Appointed As Chief Executive Officer and President of Agc Biologics
10/28/24, 3:52 PM
Location
Industry
biotechnology
health care
Position
president
chief executive officer
AGC Biologics announced the appointment of Alberto Santagostino as the new Chief Executive Officer and President, effective November 1st. Alberto brings a distinguished career in biotech, pharma, and managing large-scale global CDMO operations, and will lead the company in delivering reliable services to biopharmaceutical developers without unnecessary complications.
Company Info
Location
bothell, washington, united states
Additional Info
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from pre-clinical to commercial production, including our proprietary CHEF1TM Expression System for efficient protein production with CHO cells.